Drug Details
General Information of the Drug (ID: DR9147) | ||||
---|---|---|---|---|
Name |
DC/Dribble vaccine
|
|||
Molecular Type |
Vaccine
|
|||
Disease | Lung cancer [ICD-11: 2C25] | Phase 1 | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Elemene | Pogostemon cablin | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | IFNG | Molecule Info |
Pathway MAP
|
|
In-vitro Model | BNL1MEA.7R.1 | Hepatocellular carcinoma | Rattus norvegicus | |||
Experimental
Result(s) |
Beta-elemene combined DC/Dribble vaccine could induce specific immune cells to secrete secretory cells, thus exerting its anti-tumor effect. |